BioCentury
ARTICLE | Company News

Cellectis sales and marketing update

May 28, 2012 7:00 AM UTC

Cellectis' Cellectis stem cells business unit launched hips-HEP. The hepatocyte-like cells are derived from human induced pluripotent stem (iPS) cells and used for in vitro drug discovery, toxicity te...